Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-03-08 | Sarepta Therapeutics, Inc. | Wigzell Hans Lenn...
(Director) |
S | Common Stock | D | 15000 | $122.39 - $123.85 | $1,848,794 |
| 2024-03-08 | Sarepta Therapeutics, Inc. | Wigzell Hans Lenn...
(Director) |
M | Common Stock | A | 15000 | $13.90 - $13.90 | $208,500 |
| 2024-03-07 | Sarepta Therapeutics, Inc. | Arif Bilal
(Chief Tech Ops Officer) |
F | Common Stock | D | 978 | $120.49 - $123.14 | $119,089 |
| 2024-03-07 | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise
(Head of R&D, CSO) |
F | Common Stock | D | 1421 | $120.49 - $123.14 | $173,624 |
| 2024-03-11 | Sarepta Therapeutics, Inc. | Boor Kathryn Jean
(Director) |
S | Common Stock | D | 761 | $122.93 - $122.93 | $93,549 |
| 2024-03-07 | Sarepta Therapeutics, Inc. | Brown Ryan Edward
(EVP, General Counsel) |
F | Common Stock | D | 1405 | $120.49 - $123.14 | $171,669 |
| 2024-03-07 | Sarepta Therapeutics, Inc. | Estepan Ian Michael
(Chief Financial Officer) |
F | Common Stock | D | 1561 | $120.49 - $123.14 | $190,826 |
| 2024-03-04 | Sarepta Therapeutics, Inc. | Estepan Ian Michael
(Chief Financial Officer) |
F | Common Stock | D | 1389 | $125.32 - $125.32 | $174,069 |
| 2024-03-05 | Sarepta Therapeutics, Inc. | Mayo Stephen
(Director) |
S | Common Stock | D | 3135 | $122.96 - $122.96 | $385,479 |
| 2024-03-04 | Sarepta Therapeutics, Inc. | Brown Ryan Edward
(EVP, General Counsel) |
F | Common Stock | D | 1734 | $125.32 - $125.32 | $217,304 |
| 2024-03-04 | Sarepta Therapeutics, Inc. | Arif Bilal
(Chief Tech Ops Officer) |
F | Common Stock | D | 522 | $125.32 - $125.32 | $65,416 |
| 2024-03-04 | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise
(Head of R&D, CSO) |
F | Common Stock | D | 1728 | $125.32 - $125.32 | $216,552 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Nicaise Claude
(Director) |
A | Common Stock | A | 1846 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Mayo Stephen
(Director) |
A | Common Stock | A | 1846 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Wigzell Hans Lenn...
(Director) |
A | Common Stock | A | 1846 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Arif Bilal
(Chief Tech Ops Officer) |
S | Common Stock | D | 2000 | $128.58 - $129.71 | $257,675 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Arif Bilal
(Chief Tech Ops Officer) |
F | Common Stock | D | 365 | $126.19 - $126.19 | $46,058 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN
(Director) |
A | Common Stock | A | 1846 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Boor Kathryn Jean
(Director) |
A | Common Stock | A | 1846 | $0.00 - $0.00 | $0 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Estepan Ian Michael
(Chief Financial Officer) |
S | Common Stock | D | 1200 | $128.30 - $128.30 | $153,960 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Estepan Ian Michael
(Chief Financial Officer) |
F | Common Stock | D | 365 | $126.19 - $126.19 | $46,059 |
| 2024-03-01 | Sarepta Therapeutics, Inc. | Estepan Ian Michael
(Chief Financial Officer) |
A | Common Stock | A | 6000 | $0.00 - $0.00 | $0 |
| 2023-11-17 | Sarepta Therapeutics, Inc. | Rodino-Klapac Louise
(Head of R&D, CSO) |
F | Common Stock | D | 4508 | $82.98 - $82.98 | $374,073 |
| 2023-11-03 | Sarepta Therapeutics, Inc. | Barry Richard
(Director) |
P | Common Stock | A | 50000 | $78.81 - $78.81 | $3,940,500 |
| 2023-11-03 | Sarepta Therapeutics, Inc. | INGRAM DOUGLAS S
(President & CEO) |
P | Common Stock | A | 25225 | $78.57 - $81.26 | $2,001,799 |
| 2023-11-03 | Sarepta Therapeutics, Inc. | BEHRENS M KATHLEEN
(Director) |
M | Common Stock | A | 15000 | $29.03 - $29.03 | $435,450 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |